| Amphetamine | 🇺🇸United States | 12.5MG BASE, 15.7MG BASE, 18.8MG BASE … | tablet, orally disintegrating, extended release | Marketed | Actavis Labs FL INC |
| Amphetamine Sulfate | 🇺🇸United States | 10MG, 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG … | tablet | Marketed | Granules |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateCombination | 🇺🇸United States | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 1.875MG; 1.875MG; 1.875MG; 1.875MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | tablet | Marketed | Actavis Elizabeth |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateCombination | 🇺🇸United States | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 12.5MG; 12.5MG; 12.5MG; 12.5MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | capsule, extended release | Marketed | Ani Pharms |
| Adderall XR 5Combination | 🇺🇸United States | 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall XR 10Combination | 🇺🇸United States | 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall XR 15Combination | 🇺🇸United States | 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall XR 20Combination | 🇺🇸United States | 5MG; 5MG; 5MG; 5MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall XR 25Combination | 🇺🇸United States | 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adderall XR 30Combination | 🇺🇸United States | 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Marketed | Takeda Pharms USA |
| Adzenys XR-ODT | 🇺🇸United States | 12.5MG BASE, 15.7MG BASE, 18.8MG BASE … | tablet, orally disintegrating, extended release | Marketed | Neos Theraps |
| Dyanavel XRCombination | 🇺🇸United States | 2MG/ML; 0.5MG BASE/ML | suspension, extended release | Marketed | Tris Pharma INC |
| Dyanavel XR 10Combination | 🇺🇸United States | 8MG; 2MG BASE | tablet, extended release | Marketed | Tris Pharma INC |
| Dyanavel XR 15Combination | 🇺🇸United States | 12MG; 3MG BASE | tablet, extended release | Marketed | Tris Pharma INC |
| Dyanavel XR 20Combination | 🇺🇸United States | 16MG; 4MG BASE | tablet, extended release | Marketed | Tris Pharma INC |
| Dyanavel XR 5Combination | 🇺🇸United States | 4MG; 1MG BASE | tablet, extended release | Marketed | Tris Pharma INC |
| Evekeo | 🇺🇸United States | 10MG, 5MG | tablet | Marketed | Azurity |
| MydayisCombination | 🇺🇸United States | 12.5MG; 12.5MG; 12.5MG; 12.5MG, 3.125MG; 3.125MG; 3.125MG; 3.125MG, 6.25MG; 6.25MG; 6.25MG; 6.25MG … | capsule, extended release | Marketed | Takeda Pharms USA |
| Amphetamine | 🇺🇸United States | 10MG, 15MG, 20MG | tablet, extended release | Tentative approval | Granules Pharmaceuticals INC |
| Amphetamine | 🇺🇸United States | 12.5MG, 15.7MG, 18.8MG … | tablet, orally disintegrating | Tentative approval | Granules Pharmaceuticals INC |
| Benzedrine | 🇺🇸United States | 10MG, 5MG | Tablet | Not marketed | Smith Kline & French |
| Adderall 5Combination | 🇺🇸United States | 1.25MG; 1.25MG; 1.25MG; 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Womens |
| Adzenys ER | 🇺🇸United States | 1.25MG BASE/ML | suspension, extended release | Not marketed | Neos Theraps INC |
| Adderall 10Combination | 🇺🇸United States | 2.5MG; 2.5MG; 2.5MG; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Womens |
| Adderall 15Combination | 🇺🇸United States | 3.75MG; 3.75MG; 3.75MG; 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Womens |
